30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jennifer Jarrett

Track

Insider profile

Currently holds positions in Arena Pharmaceuticals Inc, Audentes Therapeutics Inc and Syndax Pharmaceuticals Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 74% 68% 82%
Transactions
16 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Arena Pharmaceuticals Inc June 13, 2017 -
Independent Director Audentes Therapeutics Inc June 12, 2017 -
Independent Director Syndax Pharmaceuticals Inc Sept. 25, 2018 -
Chief Financial Officer, Chief Operating Officer Arcus Biosciences Inc June 8, 2018 - Jan. 11, 2019
Chief Business and Financial Officer Arcus Biosciences Inc None -
Chief Financial Officer Medivation Inc April 23, 2016 - Sept. 28, 2016
Jennifer Jarrett's trades of Arcus Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-05-06
PrS Proposed sale
54,979
184.28
US$1,636,297 		54,979 184.28 US$1,636,297
2026-04-23 2026-04-23
PrS Proposed sale
16,117
241.81
US$1,089,342 		16,117 241.81 US$1,089,342
2026-04-08 2026-04-08
PrS Proposed sale
10,309
365.49
US$841,404 		10,309 365.49 US$841,404
2025-12-18 2025-12-17
S Sale
9,983 -4.9%
22.16
US$221,218 		9,983 -4.9% 22.16 US$221,218
2025-12-18 2025-12-16
S Sale
11,225 -5.2%
21.88
US$245,651 		11,225 -5.2% 21.88 US$245,651
2025-12-15 2025-12-16
PrS Proposed sale
22,000
21.90
US$481,800 		22,000 21.90 US$481,800
2025-11-12 2025-11-07
PlS Planned sale
50,291 -19.0%
18.97
US$954,066 		50,291 -19.0% 18.97 US$954,066
2025-10-08 2025-10-08
PlS Planned sale
37,792 -15.0%
15.05
US$568,611 		37,792 -15.0% 15.05 US$568,611
2025-10-08 2025-10-06
PlS Planned sale
12,500 -5.5%
14.54
US$181,801 		12,500 -5.5% 14.54 US$181,801
2025-10-06 2025-10-06
PrS Proposed sale
100,583
13.35
US$1,342,783 		100,583 13.35 US$1,342,783
2024-03-29 2024-03-27
PlS Planned sale
11,551 -5.1%
17.55
US$202,720 		11,551 -5.1% 17.55 US$202,720
2024-03-27 2024-03-27
PrS Proposed sale
56,551
16.90
US$955,712 		56,551 16.90 US$955,712
2024-03-20 2024-03-18
S Sale
1,296 -0.6%
18.62
US$24,132 		1,296 -0.6% 18.62 US$24,132
2024-03-20 2024-03-18
S Sale
12,153 -5.1%
17.84
US$216,810 		12,153 -5.1% 17.84 US$216,810
2024-03-15 2024-03-18
PrS Proposed sale
16,000
18.50
US$296,000 		16,000 18.50 US$296,000
2024-02-28 2024-02-27
PlS Planned sale
34,070 -12.4%
20.11
US$685,148 		34,070 -12.4% 20.11 US$685,148
2024-02-28 2024-02-26
PlS Planned sale
24,555 -8.2%
20.07
US$492,819 		24,555 -8.2% 20.07 US$492,819
2023-12-26 2023-12-22
PlS Planned sale
21,521 -7.7%
17.76
US$382,213 		21,521 -7.7% 17.76 US$382,213
2023-12-22 2023-12-22
PrS Proposed sale
80,146
17.81
US$1,427,400 		80,146 17.81 US$1,427,400
2023-12-15 2023-12-18
PrS Proposed sale
16,000
17.50
US$280,000 		16,000 17.50 US$280,000
2023-09-26 2023-09-22
PlS Planned sale
21,369 -6.6%
19.99
US$427,166 		21,369 -6.6% 19.99 US$427,166
2023-09-22 2023-09-22
PrS Proposed sale
57,494
20.48
US$1,177,477 		57,494 20.48 US$1,177,477
2023-09-15 2023-09-18
PrS Proposed sale
13,000
20.74
US$269,620 		13,000 20.74 US$269,620
2023-07-31 2023-07-28
PlS Planned sale
45,000 -11.8%
20.25
US$911,250 		45,000 -11.8% 20.25 US$911,250
2023-06-26 2023-06-22
PlS Planned sale
12,437 -3.2%
19.12
US$237,795 		12,437 -3.2% 19.12 US$237,795
2023-06-22 2023-06-22
PrS Proposed sale
57,437
19.01
US$1,091,877 		57,437 19.01 US$1,091,877
2023-06-16 2023-06-16
PlS Planned sale
12,563 -3.1%
19.35
US$243,094 		12,563 -3.1% 19.35 US$243,094
2023-06-15 2023-06-16
PrS Proposed sale
13,500
20.00
US$270,000 		13,500 20.00 US$270,000
2023-03-20 2023-03-16
S Sale
8,729 -2.1%
16.81
US$146,734 		8,729 -2.1% 16.81 US$146,734
2023-01-30 2023-01-27
PlS Planned sale
1,600 -0.4%
23.52
US$37,632 		1,600 -0.4% 23.52 US$37,632
2023-01-30 2023-01-26
PlS Planned sale
300 -0.1%
23.56
US$7,068 		300 -0.1% 23.56 US$7,068
2022-12-16 2022-12-16
S Sale
2,603 -1.7%
31.23
US$81,292 		2,603 -1.7% 31.23 US$81,292
2022-12-16 2022-12-16
PlS Planned sale
13,879 -8.5%
30.66
US$425,530 		13,879 -8.5% 30.66 US$425,530
2022-09-20 2022-09-16
S Sale
12,677 -8.8%
26.28
US$333,152 		12,677 -8.8% 26.28 US$333,152
2022-06-21 2022-06-17
S Sale
4,663 -3.8%
22.29
US$103,938 		4,663 -3.8% 22.29 US$103,938
2022-06-21 2022-06-17
S Sale
1,951 -1.6%
21.71
US$42,356 		1,951 -1.6% 21.71 US$42,356
2022-06-21 2022-06-16
PlS Planned sale
6,081 -4.6%
20.72
US$125,998 		6,081 -4.6% 20.72 US$125,998
2022-03-18 2022-03-16
S Sale
9,617 -8.3%
31.62
US$304,090 		9,617 -8.3% 31.62 US$304,090
2021-12-22 2021-12-20
PlS Planned sale
2,800 -3.0%
42.23
US$118,234 		2,800 -3.0% 42.23 US$118,234
2021-12-22 2021-12-20
PlS Planned sale
20,923 -18.3%
41.70
US$872,458 		20,923 -18.3% 41.70 US$872,458
2021-12-22 2021-12-20
PlS Planned sale
11,099 -8.8%
40.88
US$453,677 		11,099 -8.8% 40.88 US$453,677
2021-12-20 2021-12-17
S Sale
2,575 -2.0%
41.42
US$106,666 		2,575 -2.0% 41.42 US$106,666
2021-12-20 2021-12-17
S Sale
1,955 -1.5%
40.57
US$79,321 		1,955 -1.5% 40.57 US$79,321
2021-12-20 2021-12-17
S Sale
1,008 -0.8%
39.67
US$39,989 		1,008 -0.8% 39.67 US$39,989
2021-12-20 2021-12-17
S Sale
1,580 -1.2%
38.79
US$61,285 		1,580 -1.2% 38.79 US$61,285